insights_auto
Why is SOBI down 3,30%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
480,20 SEK
arrow_downward
-3,30%(-16,40) 1D
10 նոյ, 17:29:32 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
485,00 SEK
High
493,40 SEK
Low
476,80 SEK
Mkt. cap
171,74 մլրդ
Avg. vol.
361,32 հզր
Volume
717,56 հզր
P/E ratio
25,51
52-wk high
507,00 SEK
52-wk low
314,40 SEK
EPS
18,83 SEK
Shares outstanding
357,64 մլն
No. of employees
2 հզր
Open
485,00 SEK
High
493,40 SEK
Low
476,80 SEK
Mkt. cap
171,74 մլրդ
Avg. vol.
361,32 հզր
Volume
717,56 հզր
P/E ratio
25,51
52-wk high
507,00 SEK
52-wk low
314,40 SEK
EPS
18,83 SEK
Shares outstanding
357,64 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Seeking Alpha
·
29 րոպե առաջ
Anthropic opens Australian retail IPO as demand builds ahead of Nasdaq debut (ANT:Pending)
FOREX.com
·
29 րոպե առաջ
Nasdaq 100 Outlook: Slingshot rally or false dawn?
Benzinga
·
50 րոպե առաջ
Dow Falls Over 150 Points Following Inflation Report: Greed Index Remains In ‘Fear’ Zone
Yahoo Finance
·
7 ժամ առաջ
Why this top Wall Street strategist isn't bullish on the S&P 500 for 2027
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)